General Medicine and Primary Care

Host: Linda Bernstein, Pharm.D.

The U.S. Food and Drug Administration announced its approval of Ebanga (Ansuvimab-zykl) for the treatment of the ebola virus infection in adults and children. To learn more about the second ebolavirus treatment to receive approval, Dr. Linda Bernstein walks us through this new drug.

Published December 29, 2020

Host: Shira Johnson, MD

Guest: Arun Swaminath, MD

Recent studies have shown that smoking cannabis can improve some of the debilitating symptoms of inflammatory bowel disease, but the overall results are still inconclusive. Based on our current understanding, what is the impact of medical cannabis on IBD? Shira Johnson and Dr. Arun Swaminath, a practicing gastroenterologist at Northwell Health and Director of the Inflammatory Bowel Diseases Program at Lenox Hill Hospital, discuss the research of using cannabis to treat IBD.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP

Irritable bowel syndrome, or IBS, is a common disorder that can be challenging to treat. What is the best therapeutic approach to treating this condition? Dr. Peter Buch is joined by Wendy Wright, an adult and family nurse practitioner from New Hampshire, to discuss how to test and treat patients with IBS from a primary care perspective.

Host: John Russell, MD

Guest: William G. Callahan, DO

The COVID-19 pandemic has compelled many to stay home, but for those venturing out, how can we encourage them to stay safe? Dr. Bill Callahan, a family physician at Abington Jefferson Health and outdoorsman, sits down with Dr. John Russell to discuss how to stay safe during this winter pandemic.

Host: Linda Bernstein, Pharm.D.

As a growing number of pharmaceutical companies refuse to provide discounts to 340B hospitals for drugs dispensed at community-based pharmacies, a federal lawsuit is challenging the U.S. Department of Health and Human Services in order to fight for patient communities harmed by this refusal. On this episode of The Drug Report, Dr. Linda Bernstein dives into this lawsuit.

Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

Physical activity is a valuable tool in treating patients with type 2 diabetes. But there are several factors clinicians must consider before prescribing exercise, including patient preference and limitations. Dr. John Anderson sits down with Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss considerations when prescribing exercise to patients with type 2 diabetes.

Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

Exercise is an essential part of maintaining a healthy lifestyle, especially when managing a chronic condition such as type 2 diabetes. But what should we take into consideration when prescribing it? Dr. John Anderson is joined by Dr. John Jackicic, Professor in the Department of Health and Physical Activity at the University of Pittsburgh, to discuss exercise prescriptions for patients with type 2 diabetes.

Host: John E. Anderson, MD

Host: John Buse, MD, PhD

Host: Carol Wysham

Dietary decisions play a critical supporting role in the treatment of patients with type 2 diabetes. What kind of impact do these nutritional interventions have? Dr. Kathleen Stanley, a registered dietitian and certified diabetes educator with the Baptist Health Center joins Dr. John Anderson to discuss the impact of dietary recommendations on patients with type 2 diabetes.

Host: Jacob Sands, MD

Guest: Therese T. Bevers, MD

Fear of the COVID-19 pandemic has led to added safety precautions that have prevented patients from receiving much-needed cancer screenings. How will this impact the field of oncology, and what can we do to encourage patients to get their screenings? Dr. Therese Beavers, Medical Director of the Cancer Prevention Center at the University of Texas MD Anderson Cancer Center, joins Dr. Jacob Sands to discuss the fatal consequences of missed cancer screenings.

Host: Neilanjan Nandi, MD

Guest: Brennan Spiegel, MD, MSHS

Virtual reality has shown the ability to decrease pain, reduce opioid dependence, and boost mental health. How is this digital therapeutic changing the treatment landscape for gastroenterology? Dr. Neil Nandi is joined by Dr. Brennan Spiegel, Director of the Cedars-Sinai CORE program, on his innovative research about the positive impact of virtual reality in gastroenterology.